In France, two studies showed that the prevention of diabetic nephropathy is not optimal in France [24, 25], in particular the low detection rate of albuminuria and the insufficient use of inhibitors of the renin-angiotensin system in patients with diabetes [24, 25]. The gene discussed is REN; the disease is diabetes mellitus.